Objective: To compare baseline preoperative and 6-month postoperative functional health status and quality of life in patients undergoing lung cancer resection. Methods: Lung cancer surgery patients from three hospitals were administered the Short-Form 36 Health Survey (SF-36) and the Ferrans and Powers' quality-of-life index (QLI) before surgery and 6 months after surgery. Preoperative, intraoperative, hospital stay, and 6-month postoperative clinical data were collected. All p values < 0.05 were considered significant. Results: One hundred thirty-nine patients were studied; 131 patients were discharged and 8 patients (5.8%) died. One hundred three patients (78.6%) who survived underwent an evaluation at 6 months, 16 patients (12.2%) died during follow-up, 2 patients refused follow-up, 4 patients were unavailable for follow-up, and 6 patients are awaiting an evaluation at 6 months. Compared with matched healthy subjects, preoperative lung cancer patients had worse results on the SF-36 physical functioning, role-emotional, mental health, and energy subscales. 
W
hile physicians are trying to predict which patients undergoing lung cancer surgery will die or have complications, patients are worried about the risk of long-term disability associated with lung surgery. 1 This distinction is important because surgical resection remains the mainstay of curative For editorial comment see page 4 therapy for lung cancer, 2 the most common cancer killer for both genders in the United States. 3 After consideration of tumor stage, surgical candidacy is dependent on severity of comorbidities, most of which are tobacco-related lung, heart, and peripheral vascular diseases. Multiple surgical series have examined such preoperative risk factors and patient cardiopulmonary physiologic parameters in relation to operative mortality. 4 -6 The long-term goal of surgical therapy includes not only improvement in survival, but also quality of life. 7 A trend is now developing to objectively measure the quality of extended life gained with such therapy. 8 It is predicted that functional assessment of patients after health-care interventions will play a more prominent role in the future. 9 Little is known about the functional capacity and quality of life of patients after resection of lung cancer. Thus, a need exists for a more comprehensive understanding of the effects of thoracic surgery on patients' functional and quality-of-life outcomes. The potential benefit (survival and/or symptom relief) of an operation must be weighed against these outcomes, a difficult task in the face of sparse data. Follow-up of patients with cancer to determine not only raw survival data but postsurgical quality of life has been advocated. 10 The objective of this study was to characterize the preoperative and 6-month postoperative functional health status and quality of life in patients undergoing lung cancer resection. Patients' clinical characteristics and operative outcomes were correlated to preoperative and postoperative functional health status and quality of life.
Materials and Methods
We collected preoperative demographics, comorbidities, respiratory variables, and intraoperative and postoperative variables for patients referred for lung cancer resection. Functional assessment included Karnofsky performance status, American Society of Anesthesiology classification, and a 6-min walk. Respiratory variables included room air arterial blood gas analysis, complete spirometry, lung volumes and diffusion capacity of the lung for carbon monoxide (Dlco) measurement, Medical Research Council dyspnea scale results, and smoking history. Intraoperative variables included type of incision, extent of resection and lymph node dissection, operating time, estimated blood loss, and type/volume of intraoperative fluid administered. Postoperative variables included stage and cell type, complications, length of stay, discharge site, and mortality. Similar data were collected 6 months postoperatively. The Appendix details the complete listing of the Ͼ 90 demographic and clinical variables collected for each patient.
Functional health status was measured by administration of the Short-Form 36 Health Survey (SF-36), a standardized, validated, widely used instrument. 11 The SF-36 measures eight scales: physical functioning, role functioning-physical, bodily pain, general health, energy, social functioning, role functioningemotional, and mental health. Scoring is from 0 (worst) to 100 (best). Data for healthy population scores on the SF-36 are available for comparison with study populations. Quality of life was evaluated with administration of the Ferrans and Powers quality-of-life index (QLI). The QLI is a validated instrument 12 with 5 subscales. The QLI subscales include overall quality of life, health and functioning, socioeconomic status, psychological/spiritual status, and family status. Scores are from 0 (worst) to 30 (best). Finally, a visual analog pain scale, a widely used and valid instrument, 13 was administered with a scale of 0 (no pain) to 10 (worst). Patients completed these instruments preoperatively and 6 months postoperatively. All data were entered into a computerized database (Epi-info; CDC Shareware; Atlanta, GA).
Multiple thoracic surgeons performed pulmonary resections on lung cancer patients at three medical centers. The geographically and clinically diverse participating medical centers included an academic medical center, a Veterans Administration (VA) hospital, and a community tertiary-care medical center. Incisions for pulmonary resection were dictated by surgeon preference or anatomic imperatives. 14 Lobectomy was the preferred extent of resection. Pneumonectomy was performed if oncologically necessary. Less-than-lobectomy resections were performed only if mandated by preoperative physiologic impairment.
Statistical analysis consisted of serial performance of multivariate analysis of variance tests. Independent variables were the clinical characteristics or outcomes, whereas the SF-36 or QLI subscale scores were the dependent variables. When comparing preoperative and postoperative performance on a variable, repeated-measures analysis of variance was used. To compare preoperative and postoperative scores, a matched-pairs t test was used. Analysis was carried out using software (SPSS version 10.0; SPSS; Chicago, IL); p Յ 0.05 was considered significant.
To facilitate analysis, continuous variables were divided into clinically logical categories. FEV 1 was divided into Ͻ 39% predicted values, 40% to 79% predicted values, and Ͼ 80% predicted values. The 6-min walk was divided into Ͻ 1,000 feet or Ͼ 1,000 feet. Dlco was divided into Ͻ 45% predicted values, 45% to 75% predicted values, and Ͼ 75% predicted values. Age was divided into decades.
Results

Patient Population
One hundred thirty-nine patients were studied. Sixty-two patients were enrolled at the academic medical center, 16 patients were enrolled at the VA medical center, and 61 patients were enrolled at the community tertiary care medical center. The mean Ϯ SD age was 62.05 Ϯ 10.62 years (range, 31 to 86 years). Fifty-nine percent of the patients were male, 32.4% of the patients were actively employed at the time of surgery, 40.3% of the patients were active smokers within 8 weeks of surgery, and 14.4% of the patients were being treated with corticosteroids. Mean values of FEV 1 were 2.13 Ϯ 0.73 L; predicted values of FEV 1 were 76.0 Ϯ 18.4%; predicted Dlco was 67.6 Ϯ 20.3%; cigarette pack-years was 55.6 Ϯ 36.5 years; and 6-min walk results were 1,358 Ϯ 352 feet. Of the patients studied, 4.3% had undergone previous pulmonary surgery. Nonpulmonary comorbidities included cardiac (30.2%), use of digoxin or diuretics (23.7%), diabetes mellitus or its complications (15.9%), peripheral vascular disease (15.3%), and hemodialysis (2.2%). Of the patients studied, 5.8% had undergone previous chemotherapy and 6.5% had undergone previous radiation therapy. The only interinstitutional significant differences in these variables were lack of female patients and a significantly lower mean Dlco, both at the VA hospital.
Operative Characteristics
Incisions for pulmonary resection were as follows: posterolateral thoracotomy (57.6%), median sternotomy (36.7%), muscle-sparing thoracotomy (5.0%), and video-assisted thoracic surgery (0.7%). The extent of resection was as follows: lobectomy (77.7%), pneumonectomy (7.9%), segmentectomy (6.5%), chest wall resection (4.3%), and wedge resection (3.6%). Complete resection was performed on 136 patients. Operative time was 204 Ϯ 88 min. Estimated blood loss was 541 Ϯ 557 mL. Crystalloid fluid replacement was 2,228 Ϯ 1,124 mL. Colloid fluid replacement was 122 Ϯ 335 mL. Of the patients studied, 22.4% received blood transfusions.
Pathologic Stage
One hundred thirty-seven patients had complete surgical staging information (Fig 1) . Data were missing for two patients. Stage IA had 43 patients (30.9%), stage IB had 46 patients (33.1%), stage IIA had 11 patients (7.9%), stage IIB had 18 patients (12.9%), stage IIIA had 16 patients (11.5%), stage IIIB had 1 patient (0.7%), and stage IV had 2 patients (1.4%).
Postoperative Courses
One hundred thirty-one patients were discharged from the hospital. There were eight hospital deaths, for an overall mortality of 5.8%. There was no significant difference in hospital deaths between medical centers. Causes of hospital mortality included pulmonary (n ϭ 5), cancer related (n ϭ 1), infection (n ϭ 1), and other (n ϭ 1). Figure 2 illustrates postoperative complications. Mean length of stay was 8.1 Ϯ 6.3 days (range, 3 to 61 days); median length of stay was 6.0 days; 80.9% were discharged to home, 2.3% were discharged to a nursing facility, and 16.8% were discharged to an unknown location.
Six-Month Follow-up
One hundred three patients underwent a reevaluation at 6 months. Sixteen patients (12.2%) died during the 6 months of follow-up: 7 patients from cancer progression, 2 patients from respiratory failure, 1 patient from infection, and the remaining 6 patients died of unknown causes (2 patients refused follow-up and 4 patients were unavailable for followup). Six patients were awaiting reevaluation. Of the 103 patients, 13.1% underwent adjuvant chemoradiotherapy. At the 6-month follow-up, 7 patients had known metastatic disease and 22 patients were receiving pain medications. Cause of pain at 6 months included metastatic disease (n ϭ 4), postthoracotomy (n ϭ 3), neuropathic pain (n ϭ 2), and other causes (n ϭ 9). For the remainder of the patients, either no pain was noted or no data existed. Figure 3 illustrates the preoperative scores of patients with lung cancer who underwent surgery compared with age-matched, healthy control subjects from the general population. Significant impairment was noted in physical functioning (p ϭ 0.026), role functioning-emotional (p ϭ 0.004), mental health (p ϭ 0.005), and energy (p ϭ 0.044) in patients with lung cancer who underwent surgery. Interestingly, the preoperative pain subscale is better than normal (p Ͻ 0.001). Figure 4 depicts the preoperative scores vs the 6-month postoperative scores, indicating a significant persistent decline in physical 
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The analysis of preoperative and postoperative scores revealed no significant differences in the quality of life or subscales for the study group as a whole. Analysis of FEV 1 and the 6-min walk categories demonstrated no effect on preoperative or postoperative quality of life or subscales. Again, a Dlco Ͻ 45% predicted foretold significantly poor scores of the preoperative quality of life and the health and functioning subscale in addition to the postoperative quality of life, health and functioning subscale, and psychological/spiritual subscale, as demonstrated in Figure 6 . The relationship of preoperative age, FEV 1 , Dlco, and pathologic stage with the qualityof-life subscales and overall score is demonstrated in 
Discussion
This study prospectively examined preoperative and postoperative functional health status and quality of life after pulmonary resection for lung cancer in 139 patients and analyzed these scores relative to Figure 6 . QLI 6 months after lung cancer surgery, Dlco category. QL ϭ overall quality-of-life subscale; Health/func ϭ health and functioning subscale; Socioeconom ϭ socioeconomic subscale; Psych/Spirit ϭ psychological/spiritual subscale; Family ϭ family subscale. 16 found that a predicted postoperative Dlco of Ͻ 40% was the best predictor of postoperative respiratory failure, morbidity, and mortality. A discrepancy exists between what physicians view as important in the postoperative period (mortality and complications) and what patients view as important (persistent physical disability). Paradoxically, physicians attempt to predict a transient state (the postoperative period), whereas patients are concerned about their more permanent postoperative circumstances. 1 This point is underscored by our findings that although hospital mortality is an acceptable 5.8%, an additional 16 patients (12.2%) died during the 6-month follow-up period. This 6-month mortality data are disturbing and reiterate the need for improved understanding of lung cancer surgery patients for longer than the arbitrary hospital or 30-day mortality statistics that are generally reported.
The surgical literature is replete with studies 4, 6, 17, 18 examining patient demographics, cardiopulmonary physiology, and comorbidities that try to determine predictors of undesirable perioperative outcomes. Some publications have examined surrogates for functionality and quality of life. Postoperative cardiopulmonary function and exercise capacity have been examined after pulmonary resection, and demonstrated to be persistently decreased only by pneumonectomy. 19, 20 The unspoken leap of logic in such literature is that decreased cardiopulmonary capacity translates into decreased functional capacity and, presumably, quality of life for the patient.
Patient function and quality of life are outcomes that have been examined in "functional surgery" of the chest, such as lung transplantation and lung volume reduction surgery. 10, 21 However, very little data exist regarding a patient's ability to function or the quality of life after resection of lung cancer, a procedure more frequently performed by orders of magnitude than either lung transplantation or lung volume reduction surgery. In Belgium, 92 quality-of-life questionnaires were sent to referring physicians after 100 major pulmonary resections. Thirty-one questionnaires were returned and showed no correlation between pain or dyspnea and extent of resection or postoperative lung function. However, quality of life was negatively influenced by pneumonectomy. 22 Five hundred ninety patients Ն 65 years old with breast, colon, lung, or prostate cancer were studied using the SF-36 physical functioning and role functioning-physical scales. The scale results were worsened by poor physical status before surgery, surgery, or the diagnosis of lung cancer. 23 In Berlin, 20 patients were administered a quality-of-life questionnaire before surgery and serially after curative resection of lung cancer. Restrictions related to physical activities and disease symptoms predominated in decreasing quality of life, whereas emotional, social, and financial domain limitations were less frequent and less severe. In contrast to our study, Zieren et al 24 found quality of life deteriorated after discharge from the hospital but was restored within 3 to 6 months for patients who were disease free.
Restorative surgery probably has a different impact on functional health status as opposed to patients undergoing cancer excision. Four hundred fifty-four patients undergoing total hip arthroplasty, thoracic surgery to resect lung cancer, or repair of abdominal aortic aneurysm underwent serial application of SF-36 and a quality-of-life instrument up to 12 months after surgery. At 1 month after surgery, significant physical and role limitations existed, but improvement was noted at 6 months and sustained up to 12 months for the patients who underwent total hip arthroplasty and abdominal aortic aneurysm. 25 However, of the 123 patients undergoing lung cancer surgery, pain and all dimensions of health relating to physical construct declined 1 month after surgery, whereas mental health, role limitations secondary to mental health, and health perception did not decline. Subsequently, health perception declined by 6 months and remained depressed at 12 months in addition to persistent worsening of physical functioning and pain compared with preoperative levels. A contrasting report of 534 patients undergoing cardiac surgery within the Kaiser system showed significant improvement in all eight scales of the SF-36 within 3 to 6 months after surgery. 26 www.chestjournal.org CHEST / 122 / 1 / JULY, 2002
In the present study, pain is dominant in the postoperative, 6-month reevaluation. Logically, pain alone could account for most of the functional health status and quality-of-life issues identified. Incisional differences affect the possibility of long-term pain. A report of 22 video-assisted thoracic surgery (VATS) lobectomies compared with 22 thoracotomies for stage I lung cancer resection showed less chronic pain in the VATS patients. 27 We previously published a large series of lung cancer resections using either median sternotomy or posterolateral thoracotomy. Chronic pain was noted in 12% of patients who underwent posterolateral thoracotomy vs 1% of patients who underwent median sternotomy. 14 The preoperative SF-36 physical component has been shown to be a predictor of mortality after coronary artery bypass in 2,480 VA patients. 28 Conversely, quality-of-life measures were not found to be predictive of pulmonary complications in a study of 117 patients who underwent thoracotomy for possible or definite lung cancer. 29 Similarly, we detected no predictive value in the SF-36 or QLI in our 139 lung cancer surgery patients.
Information from this study should influence several clinical actions regarding lung cancer surgery. First, preoperative counseling should incorporate the findings that significant physical, emotional, social, and mental disabilities persists for at least 6 months after surgery. Second, technical modifications in the performance of lung cancer resection should be strongly considered to avoid debilitating, persistent postoperative pain. Such modifications could include minimal rib spreading during thoracotomy, VATS, or median sternotomy instead of thoracotomy as the approach of choice for lung cancer resection. In addition, participation in a formal pulmonary rehabilitation program may ameliorate the deleterious effects of both the underlying lung cancer and the operative procedure. Finally, postoperative pharmacologic intervention should be studied, such as a trial testing the effectiveness of antidepressants for several months after surgery.
Areas of future study should include the duration of postoperative multidimensional impairment and careful analysis of the impact of technical surgical modifications on functional health status and quality of life after lung cancer surgery. Basic research into the mechanism by which Dlco affects quality of life should be undertaken. Surgical societies should design and implement a simple data collection instrument, gathering essential patient data including demographics, functional status, quality of life, and physiologic parameters both before and after surgery. With multi-institutional data from a large patient population, a clinical prediction rule could be developed that would help advise pulmonologists and surgeons with a better degree of certainty who should undergo lung cancer surgery.
Conclusion
In summary, lung cancer surgery patients are sicker than the general population as documented by poorer functional status results. This depressed functional status persists for at least 6 months after surgery. Pain is a persistents postoperative complication of lung cancer surgery. A low preoperative Dlco is the only predictor of postoperative quality of life. A significant number of patients die following hospital discharge after lung cancer surgery. Preoperative chemoradiation, extent of resection, postoperative complications, and adjuvant therapy do not adversely affect functional health status or quality of life at 6 months after surgery.
APPENDIX
Abbreviations: SSN ϭ social security number; Y ϭ yes; N ϭ no; Ht ϭ height; Wt ϭ weight; Hx ϭ history; CABG ϭcoronary artery bypass graft surgery; MI ϭ myocardial infarction; vasc dis ϭ vascular disease; RA ϭ room air; TLC ϭ total lung capacity; MRC ϭ Medical Research Council; preop ϭ preoperative; pul ϭ pulmonary; rehab ϭ rehabilitation; resect ϭ resection; pneumonect ϭ pneumonectomy; LN ϭ lymph node; EBL ϭ estimated blood loss; Path ϭ pathologic; req ϭ requiring; Rx ϭ therapy; LOS ϭ length of stay; pred ϭ predicted; meds ϭ medications; Postop ϭ postoperative; rad ϭ radiation; Readmit ϭ readmission; synd ϭ syndrome; met dz ϭ metastatic disease; ASA ϭ American Society of Anesthesiologists; HGB ϭ hemoglobin; chemo ϭ chemotherapy; exam ϭ examination; adeno ϭ adeno-carcinoma; pul ϭ pulmonary. 
